文献速递骨显像与常规 SPECT放射性药物与辐射防护

核医学在诊断近期植入的下肢关节假体感染中的作用

Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties.
PubMed 文献 · Semin Nucl Med · 2017-07-26

下肢人工关节感染约三分之一在术后3个月内发生(早期),另三分之一在1年内(延迟),其余在1年后(晚期)。术后第一年诊断假体关节感染具有挑战性,疼痛几乎总会出现,发热比例从不足5%到超过40%不等。放射性核素检查可用于评估疼痛性关节置换,但术后早期应用的数据有限;骨扫描在第一年可排除感染,而铟-111标记白细胞联合骨髓显像诊断假体关节感染的准确率约为90%。

要点

  • 术后第一年内骨扫描可排除感染,是良好的排除试验,但不可靠地用于确诊感染。
  • 镓-67在正常愈合的手术切口和无菌性炎症中积聚,诊断假体关节感染的准确率为60%-80%,无论假体植入时间长短作用均有限。
  • 铟-111标记白细胞不积聚在正常愈合的手术伤口,联合骨髓显像诊断假体关节感染的准确率约为90%,初步数据显示术后早期准确率相当。

核心结论

  • 术后第一年内骨扫描可排除感染,但不可靠地用于确诊感染。
  • 镓-67诊断假体关节感染的准确率为60%-80%,无论假体年龄,在评估假体关节方面作用有限。
  • 铟-111标记白细胞联合骨髓显像诊断假体关节感染的准确率约为90%,初步数据显示术后早期准确率相当。
  • 18F-FDG诊断术后早期假体关节感染的数据缺乏,且经过近二十年研究,其诊断假体关节感染的效用仍待确立。

研究设计与样本

  • 综述,总结核医学在诊断近期植入的下肢关节假体感染中的作用。
  • 文献来源为Semin Nucl Med发表的综述。

主要发现

  • 感染约三分之一在术后3个月内发生(早期),另三分之一在1年内(延迟),其余在1年后(晚期)。
  • 发热比例从不足5%到超过40%不等,白细胞增多对感染的预测价值差。
  • 初次无并发症关节置换术后,C反应蛋白升高可持续长达3周,红细胞沉降率升高可持续长达1年。
  • 关节穿刺培养是决定性的术前诊断方法,具有特异性,但敏感性可变;平片缺乏敏感性和特异性。
  • 铟-111标记白细胞联合骨髓显像诊断假体关节感染的准确率约为90%。

关键数值与推荐

  • 镓-67诊断假体关节感染的准确率为60%-80%。
  • 铟-111标记白细胞联合骨髓显像诊断假体关节感染的准确率约为90%。
  • 发热比例从不足5%到超过40%不等。
  • 初次无并发症关节置换术后,C反应蛋白升高可持续长达3周,红细胞沉降率升高可持续长达1年。

临床怎么用

  • 放射性核素检查可用于评估疼痛性关节置换,但术后早期应用的数据有限。
  • 术后第一年内骨扫描可排除感染,是良好的排除试验,但不可靠地用于确诊感染。
  • 镓-67在正常愈合的手术切口和无菌性炎症中积聚,诊断假体关节感染的准确率为60%-80%,无论假体年龄,在评估假体关节方面作用有限。
  • 铟-111标记白细胞不积聚在正常愈合的手术伤口,联合骨髓显像诊断假体关节感染的准确率约为90%,初步数据显示术后早期准确率相当。
  • 18F-FDG诊断术后早期假体关节感染的数据缺乏,且经过近二十年研究,其诊断假体关节感染的效用仍待确立。

局限性

  • 放射性核素检查在术后早期应用的数据有限。
  • 18F-FDG诊断术后早期假体关节感染的数据缺乏。
  • 18F-FDG诊断假体关节感染的效用经过近二十年研究仍待确立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infection is an infrequent complication of lower extremity prosthetic joint surgery. Approximately one-third develop within 3 months (early), another third within 1 year (delayed), and the remainder more than 1 year (late) after surgery. Diagnosing prosthetic joint infection, especially in the early postoperative period during the first year, is challenging. Pain is almost always present. The presence of fever is variable, ranging from less than 5% to more than 40% of patients. Leukocytosis is a poor predictor of infection. After primary uncomplicated arthroplasty, the C-reactive protein remains elevated for up to 3 weeks. The erythrocyte sedimentation rate can remain elevated for up to 1 year. Although joint aspiration with culture, the definitive preoperative diagnostic procedure, is specific, its sensitivity is variable. Plain radiographs lack sensitivity and specificity. Radionuclide studies are useful for evaluating painful joint replacements, but data on their utility during the early postoperative period are limited. During the first year after arthroplasty insertion, the bone scan can exclude infection. It is a good "rule-out" test, but it is not reliable for "ruling in" infection. Gallium-67 accumulates in normally healing surgical incisions and in aseptic inflammation. With an accuracy of 60%-80% for diagnosing prosthetic joint infection, there is little role for this radiopharmaceutical for evaluating prosthetic joints, regardless of age. Although data about diagnosing prosthetic joint infection with 18F-FDG in the early postoperative period are lacking, uptake of this radiopharmaceutical in a variety of postoperative settings for variable time periods is well known. Furthermore, its utility for diagnosing prosthetic joint infection in general, after nearly 2 decades of investigation, remains to be established. Indium-111-labeled leukocytes do not accumulate in normally healing surgical wounds, and in combination with marrow imaging, the test is about 90% accurate for diagnosing prosthetic joint infection. Preliminary data indicate a comparable accuracy in the early postoperative period.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Palestro CJ, Love C. Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties. Semin Nucl Med. 2017. PMID: 28969761. doi:10.1053/j.semnuclmed.2017.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。